Deborah Byrne

Title: The Innovative Contributions of Deborah Byrne

Introduction

Deborah Byrne is a notable inventor based in Rochester, NY (US). She has made significant contributions to the field of medical diagnostics, particularly in the area of predicting and detecting diseases related to pregnancy and cardiovascular health. With a total of 2 patents, her work has the potential to impact many lives.

Latest Patents

Deborah's latest patents focus on the determination of the sFlt-1:angiogenic factor complex. These methods provide a way to determine the presence or amount of a complex comprising a first and second molecular entity, preferably an sFlt-1:PlGF complex. This determination can be utilized in predicting, detecting, and monitoring various diseases, including vascular-related diseases, cardiac conditions, cancer, and preeclampsia. The ability to detect sFlt-1:angiogenic factor complex is particularly valuable for identifying preeclampsia in the early stages of gestation, where traditional clinical evaluations may not be informative.

Career Highlights

Deborah Byrne is currently employed at Ortho-Clinical Diagnostics, Inc., where she continues to innovate in the field of diagnostics. Her work is characterized by a commitment to improving health outcomes through advanced medical technologies.

Collaborations

Deborah collaborates with talented individuals such as George Bashirians and Sarah Groulx, contributing to a dynamic team focused on groundbreaking research and development.

Conclusion

Deborah Byrne's contributions to medical diagnostics through her innovative patents highlight her role as a leading inventor in her field. Her work not only advances scientific knowledge but also has the potential to improve patient care significantly.